AMENDED AND RESTATED INDENTURE Dated as of December 19, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 6.250% SENIOR SECURED NOTES DUE 2029Indenture • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • New York
AMENDED AND RESTATED INDENTURE, dated as of December 19, 2023, among IQVIA Inc., a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent.
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF VALUEMEDICS RESEARCH, LLCLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
This Amended and Restated Limited Liability Company Agreement (this “Agreement”) is entered into as of the 23rd day of February, 2010, by IMS Health Incorporated (such person and any other person admitted as a member of the Company pursuant to Section 15 hereof individually referred to herein as a “Member” and collectively as the “Members”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • New York
This REGISTRATION RIGHTS AGREEMENT dated May 23, 2023 (this “Agreement”) is entered into by and among IQVIA Inc., a Delaware corporation (the “Issuer”), IQVIA Holdings Inc., a Delaware corporation (the “Parent”), the subsidiaries of the Issuer party hereto (the “Subsidiary Guarantors” and, together with the Parent, the “Initial Guarantors”) and Goldman Sachs & Co. LLC, as representative (the “Representative”) of the several initial purchasers listed on Schedule II of the Purchase Agreement (as defined below) (the “Initial Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • New York
This REGISTRATION RIGHTS AGREEMENT dated November 28, 2023 (this “Agreement”) is entered into by and among IQVIA Inc., a Delaware corporation (the “Issuer”), IQVIA Holdings Inc., a Delaware corporation (the “Parent”), the subsidiaries of the Issuer party hereto (the “Subsidiary Guarantors” and, together with the Parent, the “Initial Guarantors”) and J.P. Morgan Securities LLC, as representative (the “Representative”) of the several initial purchasers listed on Schedule II of the Purchase Agreement (as defined below) (the “Initial Purchasers”).
QUINTILES BIOSCIENCES HOLDINGS, LLC Limited Liability Company AgreementLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT of QUINTILES BIOSCIENCES HOLDINGS, LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act (the “Company”), is executed effective as of 12:00 p.m. U.S. Eastern Time on June 26, 2015, by its sole member, Quintiles, Inc., a North Carolina corporation.
Quintiles Laboratories, LLC Limited Liability Company AgreementLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • North Carolina
THIS LIMITED LIABILITY COMPANY AGREEMENT of Quintiles Laboratories, LLC (the “Company”), a limited liability company organized pursuant to the North Carolina Limited Liability Company Act, is executed effective as of December 31, 2011, by and between the Company and its sole Member, Quintiles, Inc., a North Carolina corporation.
SECOND AMENDED LIMITED LIABILITY COMPANY AGREEMENT OF Q SQUARED SOLUTIONS HOLDINGS LLCLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
This Second Amended and Restated Operating Agreement (the “Agreement”) of Q Squared Solutions Holdings LLC, a limited liability company organized under the Laws of the State of Delaware (the “Company”), effective as of April 1, 2021 (the “Effective Date”), is entered into by and between (i) the Company and (ii) IQVIA RDS Inc., a corporation organized under the Laws of the State of North Carolina (“RDS”), and IQVIA Pharma Inc., a corporation organized under the Laws of the State of North Carolina (“Pharma,” and together with RDS, the “Members”), as the members of the Company.
NOVELLA CLINICAL LLC Limited Liability Company AgreementLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT of NOVELLA CLINICAL LLC, a limited liability company organized pursuant to the Delaware Limited Liability Company Act (the “Company”), is executed effective as of January 1, 2015, by its sole member, Quintiles, Inc., a North Carolina corporation.
SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT among IQVIA RDS LATIN AMERICA LLC and THE MEMBERS NAMED HEREIN dated as of November 10, 2023Limited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • North Carolina
THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of IQVIA RDS Latin America LLC, a limited liability company organized pursuant to the North Carolina Limited Liability Company Act (the “Company”), is executed effective as of November 10, 2023 (“Effective Date”), by and among the Company, the Member executing this Agreement as of the Effective Date (the “Initial Member”), and each other Person who, after the Effective Date, becomes a Member of the Company and becomes a party to this Agreement by executing a joinder to this Agreement. Capitalized terms not otherwise defined herein shall have the meaning set forth in Article II.
LIMITED LIABILITY COMPANY AGREEMENT OF BUZZEOPDMA LLCLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
This Limited Liability Company Agreement (the “Agreement”) of BuzzeoPDMA LLC is entered into as of the 26th day of October, 2010 by Cegedim Inc., as the sole member of the limited liability company (the “Member”).
AMENDED AND RESTATED OPERATING AGREEMENT OF TARGETED MOLECULAR DIAGNOSTICS, LLCOperating Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Illinois
THIS AMENDED AND RESTATED OPERATING AGREEMENT (the “Agreement”) of Targeted Molecular Diagnostics, LLC (the “Company”), a limited liability company organized pursuant to the Illinois Limited Liability Company Act (the “Act”), is executed effective as of November 25, 2008 by and between the Company and its sole member, Quintiles Laboratories Limited, a North Carolina corporation (the “Member”).
LIMITED LIABILITY COMPANY AGREEMENT OF RX INDIA, LLCLimited Liability Company Agreement • January 5th, 2024 • Benefit Holding, Inc. • Services-commercial physical & biological research • Delaware
This Limited Liability Company Agreement (this “Agreement”) of RX India, LLC, a Delaware limited liability company, is entered into as of this 10th day of July, 2015, by IMS Health India Holding Corporation, as the sole member (the “Member”).
